Pieter A. Cohen
Pieter A. Cohen
Cambridge Health Alliance & Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
The Harvard Medical School-Cambridge Integrated Clerkship: An Innovative Model of Clinical Education
BMD Ogur, DMD Hirsh, EPD Krupat, DMD Bor
Academic Medicine 82 (4), 397-404, 2007
Educational outcomes of the Harvard Medical School–Cambridge integrated clerkship: A way forward for medical education
D Hirsh, E Gaufberg, B Ogur, P Cohen, E Krupat, M Cox, S Pelletier, D Bor
Academic medicine 87 (5), 643-650, 2012
Safety of herbal supplements: a guide for cardiologists
PA Cohen, E Ernst
Cardiovascular therapeutics 28 (4), 246-253, 2010
Hazards of hindsight—monitoring the safety of nutritional supplements
PA Cohen
New England journal of medicine 370 (14), 1277-1280, 2014
American roulette—contaminated dietary supplements
PA Cohen
New England Journal of Medicine 361 (16), 1523-1525, 2009
The early natural history of SARS-CoV-2 infection: clinical observations from an urban, ambulatory COVID-19 clinic
PA Cohen, LE Hall, JN John, AB Rapoport
Mayo Clinic Proceedings 95 (6), 1124-1126, 2020
Presence of banned drugs in dietary supplements following FDA recalls
PA Cohen, G Maller, R DeSouza, J Neal-Kababick
Jama 312 (16), 1691-1693, 2014
Assessing supplement safety—the FDA's controversial proposal
PA Cohen
New England Journal of Medicine 366 (5), 389-391, 2012
A methamphetamine analog (N,α‐diethyl‐phenylethylamine) identified in a mainstream dietary supplement
PA Cohen, JC Travis, BJ Venhuis
Drug testing and analysis 6 (7-8), 805-807, 2014
An amphetamine isomer whose efficacy and safety in humans has never been studied, β‐methylphenylethylamine (BMPEA), is found in multiple dietary supplements
PA Cohen, C Bloszies, C Yee, R Gerona
Drug testing and analysis 8 (3-4), 328-333, 2016
DMAA as a dietary supplement ingredient
PA Cohen
Archives of internal medicine 172 (13), 1038-1039, 2012
Probiotic safety—no guarantees
PA Cohen
JAMA internal medicine 178 (12), 1577-1578, 2018
A synthetic stimulant never tested in humans, 1, 3‐dimethylbutylamine (DMBA), is identified in multiple dietary supplements
PA Cohen, JC Travis, BJ Venhuis
Drug testing and analysis 7 (1), 83-87, 2015
Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1, 4-dimethylamylamine (1, 4-DMAA), 1, 3-dimethylamylamine (1, 3…
PA Cohen, JC Travis, PHJ Keizers, P Deuster, BJ Venhuis
Clinical toxicology 56 (6), 421-426, 2018
A new approach to determining pharmacologic adulteration of herbal weight loss products
LMD Carvalho, PA Cohen, CV Silva, APL Moreira, TM Falco, ...
Food Additives & Contaminants: Part A 29 (11), 1661-1667, 2012
Pharmaceutical quantities of yohimbine found in dietary supplements in the USA
PA Cohen, YH Wang, G Maller, R DeSouza, IA Khan
Drug testing and analysis 8 (3-4), 357-369, 2016
Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA
PA Cohen, B Avula, B Venhuis, JC Travis, YH Wang, IA Khan
Drug Testing and Analysis 9 (1), 135-142, 2017
Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF…
B Avula, PA Cohen, YH Wang, S Sagi, W Feng, M Wang, J Zweigenbaum, ...
Journal of Pharmaceutical and Biomedical Analysis 100, 243-253, 2014
Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States
PA Cohen, C Benner, D McCormick
Journal of general internal medicine 27 (1), 51-56, 2012
The supplement paradox: negligible benefits, robust consumption
PA Cohen
Jama 316 (14), 1453-1454, 2016
The system can't perform the operation now. Try again later.
Articles 1–20